These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28302502)

  • 1. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes.
    Sabatino M; Vitale G; Manfredini V; Masetti M; Borgese L; Maria Raffa G; Loforte A; Martin Suarez S; Falletta C; Marinelli G; Clemenza F; Grigioni F; Potena L
    J Heart Lung Transplant; 2017 Nov; 36(11):1217-1225. PubMed ID: 28302502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation.
    Conway J; Manlhiot C; Kirk R; Edwards LB; McCrindle BW; Dipchand AI
    J Heart Lung Transplant; 2014 Mar; 33(3):241-51. PubMed ID: 24462559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for early primary graft dysfunction after lung transplantation: a registry study.
    Kuntz CL; Hadjiliadis D; Ahya VN; Kotloff RM; Pochettino A; Lewis J; Christie JD
    Clin Transplant; 2009; 23(6):819-30. PubMed ID: 19239481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation.
    Foroutan F; Alba AC; Stein M; Krakovsky J; Chien KGW; Chih S; Guyatt G; Ross H
    J Heart Lung Transplant; 2019 Mar; 38(3):260-266. PubMed ID: 30642796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.
    Diamond JM; Arcasoy S; Kennedy CC; Eberlein M; Singer JP; Patterson GM; Edelman JD; Dhillon G; Pena T; Kawut SM; Lee JC; Girgis R; Dark J; Thabut G
    J Heart Lung Transplant; 2017 Oct; 36(10):1104-1113. PubMed ID: 28802530
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for primary graft dysfunction after lung transplantation.
    Whitson BA; Nath DS; Johnson AC; Walker AR; Prekker ME; Radosevich DM; Herrington CS; Dahlberg PS
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):73-80. PubMed ID: 16399297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent prognostic effects of recipient and donor age in adult heart transplantation.
    Bergenfeldt H; Lund LH; Stehlik J; Andersson B; Höglund P; Nilsson J
    J Heart Lung Transplant; 2019 Feb; 38(2):174-183. PubMed ID: 30502009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of extracorporeal membrane oxygenation for heart graft dysfunction in adults: incidence, risk factors and outcomes in a multicentric study.
    Noly PE; Hébert M; Lamarche Y; Cortes JR; Mauduit M; Verhoye JP; Voisine P; Flécher E; Carrier M
    Can J Surg; 2021; 64(6):E567-E577. PubMed ID: 34728522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report.
    Cypel M; Levvey B; Van Raemdonck D; Erasmus M; Dark J; Love R; Mason D; Glanville AR; Chambers D; Edwards LB; Stehlik J; Hertz M; Whitson BA; Yusen RD; Puri V; Hopkins P; Snell G; Keshavjee S;
    J Heart Lung Transplant; 2015 Oct; 34(10):1278-82. PubMed ID: 26454741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical risk factors for primary graft dysfunction in a low-volume lung transplantation center.
    Nosotti M; Palleschi A; Rosso L; Tosi D; Mendogni P; Righi I; Montoli M; Crotti S; Russo R
    Transplant Proc; 2014 Sep; 46(7):2329-33. PubMed ID: 25242781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
    Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
    Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Srivastava R; Keck BM; Bennett LE; Hosenpud JD
    Transplantation; 2000 Aug; 70(4):606-12. PubMed ID: 10972218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.
    Porteous MK; Lee JC; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamy SL; Lama VN; Bhorade SM; Crespo MM; McDyer JF; Wille KM; Localio AR; Orens JB; Shah PD; Weinacker AB; Arcasoy S; Wilkes DS; Ware LB; Christie JD; Kawut SM; Diamond JM;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1514-1522. PubMed ID: 28719755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.